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1D R A F T U N D E R R E V I E W
1. Introduction
The Net Reclassification Index (NRI) was introduced in 2008 (Pencina and others, 2008) as a
new statistic to measure the improvement in prediction performance gained by adding a marker,
Y , to a set of baseline predictors, X, for predicting a binary outcome, D. The statistic has gained
huge popularity in the applied biomedical literature. On March 13, 2013 through a search with
Google Scholar we found 840 papers (44 since January 2012) that contained the acronym ‘NRI’
and referenced Pencina and others (2008). The measure has been extended from its original
formulation (Pencina and others, 2010; Li and others, 2012). In this note we demonstrate a
fundamental problem with use of the NRI in practice. We refer to work by Hilden and Gerds
(2013) that provides insight into the source of the problems.
2. Illustration with Simulated Data
Consider a study that fits the baseline model risk(X) = P (D = 1|X) and the expanded model
risk(X, Y ) = P (D = 1|X, Y ) using a training dataset. The fitted models that we denote by
ˆrisk(X) and ˆrisk(X, Y ) are then evaluated and compared in a test dataset. The continuous NRI
statistic (Pencina and others, 2010) is calculated as
NRI = 2{P [ ˆrisk(X, Y ) > ˆrisk(X)|D = 1]− P [ ˆrisk(X, Y ) > ˆrisk(X)|D = 0]} (2.1)
the proportion of cases in the test dataset for whom ˆrisk(X, Y ) > ˆrisk(X) minus the corresponding
proportion of controls, multiplied by 2.
We generated data from a very simple simulation model described in the Supplementary
Materials where X and Y are univariate and the logistic regression models hold:
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2logitP (D = 1|X) = α0 + α1X (2.2)
logitP (D = 1|X, Y ) = β0 + β1X + β2Y . (2.3)
We used a small training set and fit logistic regression models of the correct forms in (2.2)
and (2.3). Using a large test dataset we calculated the continuous NRI statistic for the training
set derived models:
logit ˆrisk(X) = αˆ0 + αˆ1X
logit ˆrisk(X, Y ) = βˆ0 + βˆ1X + βˆ2Y .
The data were generated under the null scenario where Y does not add predictive information,
i.e., β2 = 0. The results in Table 1 indicate, however, that the NRI statistic is positive on average.
That is, the NRI statistic calculated on the test dataset tends to indicate the erroneous result
that Y contributes predictive information when in fact it does not.
We also calculated more traditional measures of performance improvement using their em-
pirical estimates in the test dataset: ∆AUC = AUC( ˆrisk(X, Y )) − AUC( ˆrisk(X)); ∆ROC(f) =
ROC(f, ˆrisk(X, Y )) − ROC(f, ˆrisk(X)); ∆SNB(t) = SNB(t, ˆrisk(X, Y )) − SNB(t, ˆrisk(X)) and
∆Brier = Brier( ˆrisk(X)) −Brier( ˆrisk(X, Y )) where
AUC(risk) = P (riskı > risk|Dı = 1, D = 0)
ROC(f, risk) = P (riskı > τ (f)|Dı = 1) where τ (f) : P (risk > τ (f)|D = 0) = f
SNB(t, risk) = P (risk > t|D = 1)− P (D = 0)
P (D = 1)
t
1− tP (risk > t|D = 0)
Brier(risk) = E(D − risk)2.
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3The AUC is the area under the receiver operating characteristic (ROC) curve. The ROC(f, risk)
measure is the proportion of cases classified as high risk when the high risk threshold is chosen as
that exceeded by no more than a proportion f of controls. The standardized net benefit, SNB(t),
is a weighted average of the true and false positive rates associated with use of the risk threshold
t to classify subjects as high risk. This is a measure known by various names in the literature,
including the decision curve (Vickers and Elkin, 2006) and the relative utility (Baker and others,
2009). The Brier score is a classic sum of squares measure. In simulation studies we set f = 0.2
for ∆ROC(f) and t = P [D = 1], the average risk, for ∆SNB(t).
In contrast to the NRI statistic, we found that changes in the two ROC based measures, the
standardized net benefit and the Brier score were negative on average in the test datasets, in
all simulation scenarios (Table 1). Negative values for measures of performance improvement in
the test dataset are appropriate because, given that Y is not predictive we expect that the fitted
model ˆrisk(X, Y ) is further from the true risk, P (D = 1|X), than is ˆrisk(X). In particular, the
model giving rise to ˆrisk(X) requires estimating only 2 parameters and takes advantage of setting
β2 at its true value, β2 = 0. In contrast, by fitting the three parameter model (2.3) that enters Y
as a predictor, we incorporate noise and variability into ˆrisk(X, Y ). The ∆Brier score, ∆ROC(f),
∆AUC and ∆SNB(t) quantify the disimprovement in the performance of ˆrisk(X, Y ) relative to
ˆrisk(X) in different ways. In contrast, the NRI statistic tends to mislead us into thinking that
the expanded model is an improvement over the baseline model.
3. Illustration with a Theoretical Example
Hilden and Gerds (2013) constructed some artificial examples of miscalibrated risk models and
showed in simulation studies that the NRI statistic can be misleading. We now consider a sim-
plified version of one of their examples and prove a theoretical large sample result. The example
provides some insight into the simulation study results. Specifically, let Y be a constant, Y = 0
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4say, and consider a model risk∗(X, Y ) that is a distorted version of the true baseline risk function
risk(X) but that contains no additional predictive information:
logit risk∗(X, Y ) = logit risk(X) + ε if risk(X) > ρ (3.4)
logit risk∗(X, Y ) = logit risk(X) − ε if risk(X) < ρ (3.5)
where ρ = P (D = 1). Result 1 below shows that the NRI > 0 for comparing the model
risk∗(X, Y ) with the baseline model risk(X). Here the training and test datasets are consid-
ered to be very large so there is no sampling variability, but the expanded model risk∗(X, Y ) is
clearly miscalibrated while the baseline model is not.
Result 1
Assume that the baseline model is not the null model,
P (risk(X) 6= ρ) > 0.
Then NRI > 0 for the model (3.4)-(3.5).
Proof
Since the baseline model is well calibrated and
P (D = 1|risk(X) > ρ) = E(risk(X)|risk(X) > ρ),
we have
P (D = 1|risk(X) > ρ) = ρ+ δ for some δ > 0.
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5NRI =2 {P (risk∗(X, Y ) > risk(X)|D = 1) − P (risk∗(X, Y ) > risk(X)|D = 0)}
=2
{
P (D = 1|risk(X) > ρ)P (risk(X) > ρ)
P (D = 1)
− P (D = 0|risk(X) > ρ)P (risk(X) > ρ)
P (D = 0)
}
=2P (risk(X) > ρ)
{
ρ+ δ
ρ
− 1− ρ− δ
1− ρ
}
=2P (risk(X) > ρ)
{
δ
ρ
+
δ
1− ρ
}
=
2δP (risk(X) > ρ)
ρ(1− ρ) > 0

We see that even in an infinitely large test dataset, the NRI associated with the expanded
model in (3.4)-(3.5) is positive despite the fact that the expanded model contains no more pre-
dictive information than the baseline model. The integrated discrimination improvement (IDI)
statistic was also proposed by Pencina and others (2008) and is quite widely used (Kerr and
others, 2011). Hilden and Gerds (2013) proved that the IDI> 0 for a different example of an
uninformed expanded model.
4. Further Results
The expanded model in Result 1 is an extreme form of a miscalibrated model. Similarly, in the
simulated data example, the expanded model derived from the small training dataset is likely to
be miscalibrated in the test dataset. This is due to the phenomenon of overfitting. Miscalibration
in the test dataset due to overfitting in the training set is likely to be exacerbated by inclusion
of multiple novel markers in the expanded model. We see in Table 2 that the effects on NRI are
more pronounced in the presence of multiple novel markers that are not predictive.
We next considered a scenario where a marker Y does add predictive information. The true
expanded model in Table 3 is
model(X, Y ) : logitP (D = 1|X, Y ) = β0 + β1X + β2Y .
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6We fit this model and a model with superfluous interaction term to the training data
model(X, Y,XY ) : logitP (D = 1|X, Y ) = γ0 + γ1X + γ2Y + γ3XY .
The test set NRIs comparing each of these fitted models with the fitted baseline model are
summarized in Table 3. For comparison we display the NRI calculated using the true risk model
parameter values. In some scenarios the NRI derived from the overfit model with interaction is
substantially larger than the true NRI. For example, when AUCX = 0.9 and AUCY = 0.7, the
average NRI is 39.92% compared with the true NRI of 28.41%.
Considering the fact that the models fit to training data should be observed to perform
worse than the true risk models, their tendency to appear better than the true risk models is
particularly disconcerting. We see from Table 3 that the ROC based measures, the Brier Score
and the net benefit all indicate that the performances of both of the expanded models fit to
training data are worse than the performance of the true risk model. Moreover, as expected, the
overfit model, model(X, Y,XY ), is generally shown to have worse performance than the model
without interaction. The NRI statistic however, only rarely conforms with this pattern. In five of
the six scenarios considered, the NRI statistic for the overfit model(X, Y,XY ) was larger than
that for the model(X, Y ). We conclude that miscalibration of the expanded model is problematic
not only when the new marker is uninformative but also when the new marker is informative. In
particular, overfitting can lead to inappropriately large values for the NRI in the test dataset.
5. Insights
Although we cannot fully explain why the NRI statistic tends to be large when the model for
risk(X, Y ) is overfit to training data, we can share a few relevant observations.
5.1 NRI is not a Proper Measure of Performance Improvement
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7Hilden and Gerds (2013) attribute the problem with the NRI statistic to the possibility that it is
not based on a ‘proper scoring rule.’ See Gneiting and Raftery (2007) for an in-depth discussion
of proper scoring rules.
In our context we need to expand on the definition of propriety. Let a population prediction
performance improvement measure (PIM) comparing r∗(X, Y ), a function of (X, Y ), to the true
baseline risk function r(X) = P (D = 1|X), be denoted by S:
PIM = S(r∗(X, Y ), r(X), F (D,X, Y ))
where F is the population distribution of (D,X, Y ).
Definition
The PIM is proper if for all F and r∗(X, Y ):
S(r(X, Y ), r(X), F (D,X, Y )) > S(r∗(X, Y ), r(X), F (D,X, Y )). (5.6)
In other words, a prediction improvement measure is proper if it is maximized at the true risk
function of (X, Y ), r(X, Y ) = P (D = 1|X, Y ). If the inequality in (5.6) is strict, then r(X, Y ) is
the unique function that maximizes S and the PIM is said to be strictly proper.
Propriety is generally considered a desirable attribute (Hilden and Gerds, 2013; Gneiting and
Raftery, 2007). An unquestionably appealing attribute of a proper PIM is that improvement
in performance cannot be due simply to disimprovement in calibration of the baseline model.
Result 1 proves with a counter example that the NRI is not proper because NRI > 0 with use
of the function risk∗(X, Y ) while NRI = 0 with use of the true risk function risk(X, Y ) that
in this example is the same as risk(X). On the other hand, it is well known from the theory of
least squares that the change in the Brier score is proper, a fact that follows from the equality
E(D|X, Y ) = risk(X, Y ). In addition, the ∆AUC and ∆ROC(f) measures are proper since the
ROC curve for (X, Y ) is maximized at all points by the risk function (McIntosh and Pepe, 2002).
Interestingly, these are not strictly proper measures because ROC curves are also maximized
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8by any monotone increasing function of the risk. We show in supplementary materials that the
change in the standardized net benefit, ∆SNB(t), is proper. Being proper measures of prediction
improvement appears to translate into more sensible comparisons of risk models in our simulation
studies. In particular, distortion of the baseline model by adding unnecessary predictors to the
model does not increase the estimated values of the proper performance measures but can increase
the NRI.
5.2 Manifestations of Overfitting
When risk models include superfluous predictor variables, predictions are apt to predict more
poorly than predictions derived from models without them. In Figure 1 we demonstrate this
for one simulated dataset corresponding to the scenario in the second-to-last row of Table 1.
Observe that the predictions from the baseline model, ˆrisk(X), are seen to be closer to the
true risk, risk(X), than are the more variable predictions based on ˆrisk(X, Y ), where Y is an
uninformative variable that is therefore superfluous. The NRI statistic does not acknowledge the
poorer predictions while the other performance improvement measures do (Figure 1 caption).
We compared the estimated odds ratios for X in the overfit models described in Table 2 with
that in the fitted baseline model. Results shown in Table 4 indicate that odds ratios are biased
too large in the overfit models. This presumably provides some rationale for use of shrinkage
techniques to address problems with overfitting (Hastie and others (2001), section 10.12.1). In-
terestingly, when the odds ratio for X is larger in an overfit model than in the baseline model, the
NRI statistic is generally positive (Figure 2). We now provide some intuition for this observation.
Note that the NRI statistic compares ˆrisk(X, Y ) with ˆrisk(X) for each individual. Assuming that
the intercept terms center X at 0 but otherwise can be ignored, the NRI statistic adds positive
contributions when
βˆ1X + βˆ2Y > αˆ1X and D = 1 (5.7)
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9and when
βˆ1X + βˆ2Y < αˆ1X and D = 0. (5.8)
But since X is large (positive) in cases and small (negative) in controls, the inequalities (5.7)
and (5.8) tend to hold because of the tendency for βˆ1 > αˆ1. Note that Y is centered at 0 and βˆ2
is likely to be small in the simulations because β2 = 0. In the simulation scenario corresponding
to Figure 2 (and the second-to-last rows of Tables 1 and 4) we found that βˆ1 > αˆ1 in 66.4%
of simulated datasets leading to NRI> 0 in 66.9% of datasets and an average NRI of 6.56%
(Table 1). In supplementary materials (figure A.1-A.4) we see that for the same scenario, the
∆ROC(0.2), ∆SNB(ρ), ∆AUC and ∆Brier statistics were generally negative regardless of the
comparative values of αˆ1 and βˆ1.
6. Discussion
The simulation and theoretical results provided here and in Hilden and Gerds (2013) demonstrate
that the NRI statistic can be biased large by use of miscalibrated risk models. Of particular con-
cern is the fact that models overfit to training data can appear to improve prediction performance
when evaluated with test data even when they do not actually improve prediction performance.
Even small amounts of overfitting, by adding a single unnecessary predictor, lead to biased test
set evaluations in our simulation studies. Following the same logic, this sort of bias is likely
also to be manifested in cross-validated estimates of the NRI although we have not specifically
investigated the phenomenon here.
In practice, one should not use the NRI statistic, or other prediction improvement performance
measures such as ∆AUC, ∆ROC(f), ∆SNB(t), or ∆Brier for that matter, to determine if there
is predictive information in a novel marker Y . We have argued previously that testing the null
hypothesis about the regression coefficient associated with Y in the risk model risk(X, Y ) is
equivalent and more powerful to tests based on estimates of prediction improvement performance
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measures (Pepe and others, 2013).
On the other hand, for quantifying the improvement in prediction performance one must
choose summary statistics. There has been much debate in the literature about which measures
are most appropriate (Pepe and Janes, 2013). Arguments have centered on the interpretations
and clinical relevance of various measures. The results in this paper and in Hilden and Gerds
(2013) add another dimension to the debate. Regardless of the intuitive appeal that the NRI
statistic may garner, its potential for being inflated by miscalibrated or over-fit models is a very
serious concern.
Our results underscore the need to check model calibration as a crucial part of the exercise of
evaluating risk prediction models. In additional simulation studies (results not shown) we found
that after recalibrating the training set models to the test dataset, problems with inflated NRIs
were much reduced. However, guaranteeing well fitting risk models in practical applications is
not always possible. For this reason, other statistical measures of prediction improvement that
cannot be made large by miscalibration may be preferred for practical application. We especially
encourage use of the change in the standardized net benefit statistic and its components, the
changes in true and false positive rates, calculated at a relevant risk threshold, because, not only
is it a proper prediction improvement statistic, but it also quantifies prediction performance in
a clinically meaningful way (Pepe and Janes, 2013; Vickers and Elkin, 2006; Baker and others,
2009).
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Tables and Figures
Table 1. Measures of improvement in prediction when risk models, logitP (D = 1|X) = α0 + α1X and
logitP (D = 1|X,Y ) = β0 + β1X + β2Y , are fit to a training dataset and applied to a test dataset. The
novel marker Y does not improve prediction: the true models are linear logistic (2.2) and (2.3) with
coefficients: β2 = 0, β1 = α1 and β0 = α0. Performance measures are averaged over 1000 simulations.
Data generation is described in Supplementary Materials
One Uninformative Marker
Simulation Scenario
Performance Increment ×100
Average (standard error)
ρ = P (D = 1) AUCX
1 N -training2 N -test3 NRI ∆ROC(0.2) ∆AUC ∆Brier ∆SNB(ρ)
0.1 0.6 250 25,000 0.27(0.09) −1.70(0.09) −1.28(0.08) −0.044(0.002) −1.85(0.12)
0.1 0.7 250 25,000 1.38(0.16) −1.37(0.07) −0.86(0.05) −0.049(0.002) −1.31(0.07)
0.1 0.8 250 25,000 3.22(0.28) −0.90(0.05) −0.48(0.02) −0.058(0.003) −0.80(0.04)
0.1 0.9 250 25,000 7.72(0.52) −0.52(0.03) −0.25(0.01) −0.066(0.003) −0.57(0.03)
0.5 0.6 50 5,000 0.57(0.15) −1.67(0.12) −1.19(0.11) −0.479(0.023) −1.69(0.15)
0.5 0.7 50 5,000 2.78(0.28) −2.59(0.12) −1.69(0.08) −0.540(0.024) −2.49(0.13)
0.5 0.8 50 5,000 6.56(0.47) −1.83(0.09) −1.00(0.05) −0.492(0.022) −1.62(0.08)
0.5 0.9 50 5,000 17.09(0.91) −1.11(0.05) −0.56(0.03) −0.433(0.021) −1.17(0.06)
1Area under the ROC curve for the baseline model (X)
2Size of training dataset
3Size of test dataset
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Table 2. Measures of improvement in prediction ×100 when risk models are fit to a training dataset of
50 observations and assessed on a test dataset of 5000 observations where P (D = 1) = 0.5. The linear
logistic regression models fit to the training data are (i) baseline logitP (D = 1|X) = α0 + α1X ; (ii)
model(X,Y1) : logitP (D = 1|X,Y1) = β0+β1X+β2Y1; (iii) model(X,Y1, Y2) : logitP (D = 1|X,Y1, Y2) =
γ0 + γ1X + γ2Y1 + γ3Y2. Data generation is described in Supplementary Materials. Shown are averages
over 1000 simulations. Neither Y1 nor Y2 are informative — the true values of β2, γ2, and γ3 are zero.
Two Uninformative Markers
NRI ∆ROC(0.2) ∆AUC ∆ Brier ∆SNB(ρ)
Model (X,Y1) (X,Y1, Y2) (X,Y1) (X,Y1, Y2) (X,Y1) (X,Y1, Y2) (X,Y1) (X,Y1, Y2) (X,Y1) (X,Y1, Y2)
AUCX
0.60 0.61 0.78 −1.81 −2.91 −1.30 −2.18 −0.55 −1.12 −1.84 −3.06
0.70 2.08 3.63 −2.63 −4.55 −1.66 −2.95 −0.52 −1.08 −2.44 −4.36
0.80 6.18 10.60 −1.75 −3.50 −0.95 −1.89 −0.47 −0.96 −1.61 −3.14
0.90 17.83 28.00 −1.33 −2.57 −0.65 −1.27 −0.51 −1.03 −1.36 −2.63
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Table 3. Measures of improvement in prediction when risk models are fit to a training dataset of N -training=50 observations and assessed
on a test dataset of N -test=5000 observations where P (D = 1) = 0.5. The linear logistic regression models fit to the training datasets are
(i) baseline logitP (D = 1|X) = α0 + α1X ; (ii) model(X,Y ) : logitP (D = 1|X,Y ) = β0 + β1X + β2Y ; (iii) model(X,Y, XY ) : logitP (D =
1|X,Y ) = γ0 + γ1X + γ2Y + γ3XY . The marker Y is informative and the correct model is model(X,Y ) while the model(X,Y, XY ) is overfit.
Data generation is described in Supplementary Materials. Shown are the true values of the performance measures (True) that use the true risk,
as well as averages of estimated performance using training and test data over 1,000 simulations. All measures shown as %.
One Informative Marker
NRI ∆ROC(0.2) ∆AUC ∆Brier ∆SNB(ρ)
AUCX AUCY True
Model
(X,Y )
Model
(X,Y,XY) True
Model
(X, Y )
Model
(X,Y,XY) True
Model
(X,Y )
Model
(X,Y,XY) True
Model
(X,Y )
Model
(X,Y,XY) True
Model
(X,Y )
Model
(X,Y,XY)
0.7 0.7 28.32 23.37 22.74 3.25 0.99 −0.89 1.98 0.64 −0.69 0.61 0.16 −0.41 3.21 0.98 −0.40
0.8 0.7 28.39 23.37 27.03 1.97 0.14 −1.13 1.03 0.06 −0.80 0.47 0.01 −0.45 1.84 0.15 −0.90
0.8 0.8 57.84 55.65 55.82 7.73 6.09 4.99 3.94 3.12 2.25 1.89 1.48 1.00 7.10 5.39 4.59
0.9 0.7 28.41 27.16 39.92 0.88 − 0.31 −1.15 0.43 −0.16 −0.77 0.29 −0.16 −0.59 0.92 −0.33 −1.25
0.9 0.8 57.87 57.13 63.05 3.40 2.31 1.61 1.69 1.14 0.53 1.19 0.74 0.30 3.79 2.49 1.71
0.9 0.9 89.58 87.02 88.18 7.35 6.46 5.59 3.74 3.23 2.54 2.81 2.40 1.95 8.85 7.50 6.74
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Table 4. Average estimated odds ratios for X in models fit to training data generated using the same
settings as in Table 2. Both Y1 and Y2 are uninformative markers.
True Baseline Model Model (X,Y1) Model (X,Y1, Y2)
AUCX exp(α1) exp(αˆ1) exp(βˆ1) exp(γˆ1)
0.6 1.43 1.56 1.58 1.60
0.7 2.10 2.46 2.55 2.63
0.8 3.29 4.02 4.24 4.49
0.9 6.13 6.78∗ 7.37∗ 8.23∗
∗medians displayed when distribution is highly skewed
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Fig. 1. Risk estimates calculated, using models fit to training data, on a test data set of 5000 observations.
Data were simulated from the scenario shown in the second to last row of Table 1. Values of performance
improvement statistics are: NRI= 33.95%, ∆ROC(0.2) = −1.65%, ∆AUC= −0.37%, ∆Brier= −0.54%
and ∆SNB(ρ) = −1.77%. The thick curve is ˆrisk(X) while the thin curve is a lowess curve through the
points ˆrisk(X,Y ) that are displaed with light circles.
     












	
		







	


http://biostats.bepress.com/uwbiostat/paper392
19
Fig. 2. Scatterplots showing the relationship between the NRI statistic (×100) and βˆ1 − αˆ1 in 1000
simulated datasets generated according to the scenario shown in the second to last row of Table 1. The
coefficients are calculated by fitting the models logitP (D = 1|X) = α0+α1X and logitP (D = 1|X,Y ) =
β0 + β1X + β2Y to the training data. The NRI is calculated using the test dataset.
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SUPPLEMENTARY MATERIALS
A.1 Data Generation
The simulations reported in Table 1 are based on data generated as
(
X
Y
)
∼ N
((
µXD
0
)
,
(
1 0
0 1
))
where D is random binary variable with specified P (D = 1). We chose µX =
√
2 Φ−1(AUCX) so
that the AUC for the baseline model was fixed by design.
Data for Table 2 were simulated as

XY1
Y2

 ∼ N



µXD0
0

 ,

1 0 00 1 0
0 0 1



 .
Data for Table 3 were generated from the distribution
(
X
Y
)
∼ N
((
µXD
µYD
)
,
(
1 0
0 1
))
where µX =
√
2Φ−1(AUCX) and µY =
√
2Φ−1(AUCY ).
A.2 Net Benefit is a Proper Scoring Statistic
Let X denote the available predictors and let r∗(X) and r(X) be two functions of X. Assume
that the true model is P (D = 1|X) = r(X) and the aim is to assess the decision rule based
on the model r∗(X) defined by r∗(X) > t. The standardized net benefit statistic at threshold t
associated with the function r∗(X) is
SNB(t, r∗(X)) = P (r∗(X) > t|D = 1)− 1− ρ
ρ
t
1− tP (r
∗(X) > t|D = 0)
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where ρ = P (D = 1). In terms of expectation over the marginal distribution of X, we write
ρSNB(t, r∗(X)) = E
{
I(r∗(X) > t, D = 1)− t
1− t I(r
∗(X) > t, D = 0)
}
= E
{
P (D = 1|X)I(r∗(X) > t) − t
1− t [1− P (D = 1|X)]I(r
∗(X) > t)
}
= E
{
I(r∗(X) > t)[r(X) − t
1− t (1 − r(X))]
}
= E
{
I(r∗(X) > t)[
r(X)− t
1− t ]
}
.
Now consider the difference between ρSNB(t, r(X)) and ρSNB(t, r∗(X)) : ρ(SNB(t, r(X)) −
SNB(t, r∗(X))) = 1
1−t
E{(r(X) − t)(I(r(X) > t)− I(r∗(X)) > t))}
The entity inside the expectation, namely
(r(X) − t){I(r(X) > t) − I(r∗(X) > t)} (A.1)
is non-negative with probability 1. To see this, consider the various cases possible: (i) r(X) = t;
(ii) r(X) > t, r∗(X) > t; (iii) r(X) > t, r∗(X) < t (iv) r(X) < t, r∗(X) < t and (v) r(X) <
t, r∗(X) > t and observe that A.1 is > 0 in each case. Therefore the expectation is nonnegative.
In other words,
SNB(t, r(X))) > SNB(t, r∗(X))
for every function r∗(X). That is, SNB(t, r∗(X)) is maximized by r∗(X) = r(X), the true risk
function.
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Figure A.1. Scatterplots showing the relationship between the ∆ROC(0.2) statistic (×100) and
βˆ1−αˆ1 in 1000 simulated datasets generated according to the scenario shown in the second to last
row of Table 1. The coefficients are calculated by fitting the models logitP (D = 1|X) = α0+α1X
and logitP (D = 1|X, Y ) = β0 + β1X + β2Y to the training data. The ∆ROC(0.2) is calculated
using the test dataset.
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Figure A.2. Scatterplots showing the relationship between the ∆SNB(ρ) statistic (×100) and
βˆ1−αˆ1 in 1000 simulated datasets generated according to the scenario shown in the second to last
row of Table 1. The coefficients are calculated by fitting the models logitP (D = 1|X) = α0+α1X
and logitP (D = 1|X, Y ) = β0 + β1X + β2Y to the training data. The ∆SNB(ρ) is calculated
using the test dataset.
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Figure A.3. Scatterplots showing the relationship between the ∆AUC statistic (×100) and
βˆ1−αˆ1 in 1000 simulated datasets generated according to the scenario shown in the second to last
row of Table 1. The coefficients are calculated by fitting the models logitP (D = 1|X) = α0+α1X
and logitP (D = 1|X, Y ) = β0 + β1X + β2Y to the training data. The ∆AUC is calculated using
the test dataset.
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Figure A.4. Scatterplots showing the relationship between the ∆Brier statistic (×100) and
βˆ1−αˆ1 in 1000 simulated datasets generated according to the scenario shown in the second to last
row of Table 1. The coefficients are calculated by fitting the models logitP (D = 1|X) = α0+α1X
and logitP (D = 1|X, Y ) = β0 + β1X + β2Y to the training data. The ∆Brier is calculated using
the test dataset.
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